Steward Partners Investment Advisory’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$96.9K Buy
1,992
+552
+38% +$26.8K ﹤0.01% 2134
2025
Q1
$49K Buy
1,440
+579
+67% +$19.7K ﹤0.01% 2389
2024
Q4
$33.9K Sell
861
-87
-9% -$3.42K ﹤0.01% 2539
2024
Q3
$44.5K Sell
948
-191
-17% -$8.97K ﹤0.01% 2287
2024
Q2
$61.5K Sell
1,139
-403
-26% -$21.8K ﹤0.01% 2001
2024
Q1
$105K Sell
1,542
-460
-23% -$31.4K ﹤0.01% 1743
2023
Q4
$125K Buy
2,002
+18
+0.9% +$1.13K ﹤0.01% 1582
2023
Q3
$90.1K Buy
1,984
+31
+2% +$1.41K ﹤0.01% 1631
2023
Q2
$110K Sell
1,953
-35
-2% -$1.97K ﹤0.01% 1546
2023
Q1
$89.9K Sell
1,988
-20
-1% -$905 ﹤0.01% 1631
2022
Q4
$81.6K Buy
2,008
+95
+5% +$3.86K ﹤0.01% 1626
2022
Q3
$125K Sell
1,913
-31
-2% -$2.03K ﹤0.01% 1401
2022
Q2
$118K Buy
1,944
+148
+8% +$8.98K ﹤0.01% 1432
2022
Q1
$113K Buy
1,796
+1,093
+155% +$68.8K ﹤0.01% 1556
2021
Q4
$53K Sell
703
-348
-33% -$26.2K ﹤0.01% 1875
2021
Q3
$118K Sell
1,051
-719
-41% -$80.7K ﹤0.01% 1480
2021
Q2
$287K Sell
1,770
-2,384
-57% -$387K ﹤0.01% 1211
2021
Q1
$506K Buy
4,154
+3,237
+353% +$394K 0.01% 884
2020
Q4
$140K Buy
917
+544
+146% +$83.1K ﹤0.01% 1219
2020
Q3
$31K Buy
373
+73
+24% +$6.07K ﹤0.01% 1708
2020
Q2
$22K Hold
300
﹤0.01% 1728
2020
Q1
$12K Hold
300
﹤0.01% 1780
2019
Q4
$18K Hold
300
﹤0.01% 1800
2019
Q3
$12K Hold
300
﹤0.01% 1902
2019
Q2
$14K Buy
+300
New +$14K ﹤0.01% 1829
2018
Q4
Sell
-300
Closed -$13K 1029
2018
Q3
$13K Buy
300
+200
+200% +$8.67K ﹤0.01% 1756
2018
Q2
$6K Hold
100
﹤0.01% 1920
2018
Q1
$4K Buy
+100
New +$4K ﹤0.01% 1837